In addition, miR-103 promotes the proliferation of pulmonary arterial smooth muscle cells (PASMCs) and relieves pulmonary hypertension by regulating the hypoxia-inducible factor-1β (HIF-1β) pathway [43]. Here, ARNT is linked to pulmonary arterial hypertension.